Search research articles
Contact Us
Filters
Showing results (221-230 of 234) with videos related to
Page
of 24
Sort By:
The Lancet. Haematology
|
March 27, 2019
Conditioning with busulfan plus melphalan versus melphalan alone before autologous haemopoietic cell transplantation for multiple myeloma: an open-label, randomised, phase 3 trial
Qaiser Bashir, Peter F Thall, Denái R Milton, et al.
Haematologica
|
May 6, 2021
Improved outcomes of high-risk relapsed Hodgkin lymphoma patients after high-dose chemotherapy: a 15-year analysis
Yago Nieto, Stephen Gruschkus, Benigno C Valdez, et al.
The New England Journal of Medicine
|
December 14, 2012
Cord-blood engraftment with ex vivo mesenchymal-cell coculture
Marcos de Lima, Ian McNiece, Simon N Robinson, et al.
Bone Marrow Transplantation
|
February 15, 2024
Outcomes of toxoplasmosis after allogeneic hematopoietic stem cell transplantation and the role of antimicrobial prophylaxis
Alexandre E Malek, Taha Al-Juhaishi, Denái R Milton, et al.
Nature Medicine
|
June 26, 2025
Author Correction: Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trial
Yago Nieto, Pinaki Banerjee, Indreshpal Kaur, et al.
Nature Medicine
|
April 4, 2025
Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trial
Yago Nieto, Pinaki Banerjee, Indreshpal Kaur, et al.
Blood Advances
|
July 15, 2021
CRP and ferritin in addition to the EASIX score predict CAR-T-related toxicity
Uri Greenbaum, Paolo Strati, Rima M Saliba, et al.
Nature Medicine
|
January 18, 2024
Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19<sup>+</sup> B cell tumors: a phase 1/2 trial
David Marin, Ye Li, Rafet Basar, et al.
Blood Cancer Journal
|
March 28, 2026
Impact of allogeneic stem cell transplantation in patients with higher risk myelodysplastic syndromes
Alexandre Bazinet, Alex Bataller, Kelly Chien, et al.
The Journal of Clinical Investigation
|
August 3, 2016
Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells
Partow Kebriaei, Harjeet Singh, M Helen Huls, et al.
Page
of 24
Search research articles
Search
Showing results (221-230 of 234) with videos related to
Sort By:
Page
of 24
The Lancet. Haematology
|
March 27, 2019
Conditioning with busulfan plus melphalan versus melphalan alone before autologous haemopoietic cell transplantation for multiple myeloma: an open-label, randomised, phase 3 trial
Qaiser Bashir, Peter F Thall, Denái R Milton, et al.
Haematologica
|
May 6, 2021
Improved outcomes of high-risk relapsed Hodgkin lymphoma patients after high-dose chemotherapy: a 15-year analysis
Yago Nieto, Stephen Gruschkus, Benigno C Valdez, et al.
The New England Journal of Medicine
|
December 14, 2012
Cord-blood engraftment with ex vivo mesenchymal-cell coculture
Marcos de Lima, Ian McNiece, Simon N Robinson, et al.
Bone Marrow Transplantation
|
February 15, 2024
Outcomes of toxoplasmosis after allogeneic hematopoietic stem cell transplantation and the role of antimicrobial prophylaxis
Alexandre E Malek, Taha Al-Juhaishi, Denái R Milton, et al.
Nature Medicine
|
June 26, 2025
Author Correction: Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trial
Yago Nieto, Pinaki Banerjee, Indreshpal Kaur, et al.
Nature Medicine
|
April 4, 2025
Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trial
Yago Nieto, Pinaki Banerjee, Indreshpal Kaur, et al.
Blood Advances
|
July 15, 2021
CRP and ferritin in addition to the EASIX score predict CAR-T-related toxicity
Uri Greenbaum, Paolo Strati, Rima M Saliba, et al.
Nature Medicine
|
January 18, 2024
Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19<sup>+</sup> B cell tumors: a phase 1/2 trial
David Marin, Ye Li, Rafet Basar, et al.
Blood Cancer Journal
|
March 28, 2026
Impact of allogeneic stem cell transplantation in patients with higher risk myelodysplastic syndromes
Alexandre Bazinet, Alex Bataller, Kelly Chien, et al.
The Journal of Clinical Investigation
|
August 3, 2016
Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells
Partow Kebriaei, Harjeet Singh, M Helen Huls, et al.
Page
of 24